Literature DB >> 14728976

Developmental toxicity of dioxin to mouse embryonic teeth in vitro: arrest of tooth morphogenesis involves stimulation of apoptotic program in the dental epithelium.

Anna Maija Partanen1, Anu Kiukkonen, Carin Sahlberg, Satu Alaluusua, Irma Thesleff, Raimo Pohjanvirta, Pirjo Liisa Lukinmaa.   

Abstract

Previous studies have shown that 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) can arrest molar tooth development in rats after in utero and lactational exposure, and that the sensitive stage is temporally restricted. To define the stage in which TCDD is able to arrest tooth development and the cellular background of the effect, mouse embryonic molar tooth explants including various early developmental stages from initiation to late cap stage were exposed to TCDD in organ culture. TCDD did not inhibit morphogenesis of the first molar teeth including the early bud-staged E12 first molars, but the teeth were smaller than in control cultures. Accordingly, the second molars underwent morphogenesis in the presence of TCDD when explanted at E15 when they were at the bud stage. TCDD arrested their development when explanted at E14 when they had not yet reached the early bud stage. Immunohistochemical localization of incorporated bromodeoxyuridine in cultured E14 teeth showed that TCDD did not affect cell proliferation. Localization of apoptosis by terminal deoxynucleotidyl transferase (TdT)-mediated nick end labeling (TUNEL) method revealed that TCDD enhanced apoptosis of dental epithelial cells, especially in the dental lamina of both the first and second molars, and in the inner dental epithelium at the cusp tips of the first molars. Thus, TCDD can arrest tooth development in vitro if the exposure starts at the initiation stage, whereas exposure at later stages leads to smaller tooth size and deformation of cuspal morphology. TCDD interferes with tooth development by stimulating apoptosis in those cells of the dental epithelium, which are predetermined to undergo apoptosis during normal development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14728976     DOI: 10.1016/j.taap.2003.08.014

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  6 in total

1.  Qualitative effects of dioxin on molars vary among inbred mouse strains.

Authors:  J M Keller; Y M Huet-Hudson; L J Leamy
Journal:  Arch Oral Biol       Date:  2006-12-04       Impact factor: 2.633

2.  Molar-incisor-hypomineralisation and dioxins: new findings.

Authors:  S Laisi; H Kiviranta; P-L Lukinmaa; T Vartiainen; S Alaluusua
Journal:  Eur Arch Paediatr Dent       Date:  2008-12

3.  Antineoplastic chemotherapy and congenital tooth abnormalities in children and adolescents.

Authors:  Ewa Krasuska-Sławińska; Agnieszka Brożyna; Bożenna Dembowska-Bagińska; Dorota Olczak-Kowalczyk
Journal:  Contemp Oncol (Pozn)       Date:  2016-12-20

4.  Assessment of Selected Morphological, Physical and Chemical Parameters of the Teeth of the Offspring of Female Rats Exposed to 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), Taking into Account the Protective Role of Selected Antioxidants-Preliminary Study.

Authors:  Maciej Dobrzyński; Anna Nikodem; Joanna Klećkowska-Nawrot; Karolina Goździewska-Harłajczuk; Maciej Janeczek; Marzena Styczyńska; Piotr Kuropka
Journal:  Animals (Basel)       Date:  2022-02-16       Impact factor: 2.752

5.  Developmental dental aberrations after the dioxin accident in Seveso.

Authors:  Satu Alaluusua; Pier Calderara; Pier Mario Gerthoux; Pirjo-Liisa Lukinmaa; Outi Kovero; Larry Needham; Donald G Patterson; Jouko Tuomisto; Paolo Mocarelli
Journal:  Environ Health Perspect       Date:  2004-09       Impact factor: 9.031

6.  Roles for B[a]P and FICZ in subchondral bone metabolism and experimental temporomandibular joint osteoarthritis via the AhR/Cyp1a1 signaling axis.

Authors:  Yuri Yoshikawa; Takashi Izawa; Yusaku Hamada; Hiroko Takenaga; Ziyi Wang; Naozumi Ishimaru; Hiroshi Kamioka
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.